nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—HTR2B—Raloxifene—breast cancer	0.288	1	CbGbCtD
Amisulpride—Sulpiride—CA9—breast cancer	0.00377	0.336	CrCbGaD
Amisulpride—Metoclopramide—CYP17A1—breast cancer	0.00285	0.254	CrCbGaD
Amisulpride—Sulpiride—BCHE—breast cancer	0.00231	0.205	CrCbGaD
Amisulpride—Remoxipride—CYP2D6—breast cancer	0.00151	0.135	CrCbGaD
Amisulpride—Metoclopramide—CYP2D6—breast cancer	0.000793	0.0707	CrCbGaD
Amisulpride—Malnutrition—Docetaxel—breast cancer	0.000303	0.000536	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000302	0.000535	CcSEcCtD
Amisulpride—Dyspepsia—Fluorouracil—breast cancer	0.000301	0.000534	CcSEcCtD
Amisulpride—Nausea—Tamoxifen—breast cancer	0.000301	0.000533	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Gemcitabine—breast cancer	0.0003	0.000532	CcSEcCtD
Amisulpride—Fatigue—Gemcitabine—breast cancer	0.0003	0.000532	CcSEcCtD
Amisulpride—Cardiac arrest—Doxorubicin—breast cancer	0.000298	0.000528	CcSEcCtD
Amisulpride—Constipation—Gemcitabine—breast cancer	0.000298	0.000527	CcSEcCtD
Amisulpride—Dry mouth—Paclitaxel—breast cancer	0.000297	0.000527	CcSEcCtD
Amisulpride—Asthenia—Thiotepa—breast cancer	0.000297	0.000526	CcSEcCtD
Amisulpride—Diarrhoea—Vinorelbine—breast cancer	0.000296	0.000525	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000295	0.000524	CcSEcCtD
Amisulpride—Mental disorder—Capecitabine—breast cancer	0.000295	0.000523	CcSEcCtD
Amisulpride—Nausea—Melphalan—breast cancer	0.000294	0.000522	CcSEcCtD
Amisulpride—Malnutrition—Capecitabine—breast cancer	0.000293	0.000519	CcSEcCtD
Amisulpride—Neutropenia—Methotrexate—breast cancer	0.000293	0.000519	CcSEcCtD
Amisulpride—Pruritus—Thiotepa—breast cancer	0.000293	0.000519	CcSEcCtD
Amisulpride—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000292	0.000518	CcSEcCtD
Amisulpride—Gastrointestinal pain—Irinotecan—breast cancer	0.000292	0.000518	CcSEcCtD
Amisulpride—Muscle spasms—Docetaxel—breast cancer	0.000291	0.000516	CcSEcCtD
Amisulpride—Erectile dysfunction—Methotrexate—breast cancer	0.000288	0.000511	CcSEcCtD
Amisulpride—Nausea—Goserelin—breast cancer	0.000287	0.000509	CcSEcCtD
Amisulpride—Dizziness—Vinorelbine—breast cancer	0.000286	0.000508	CcSEcCtD
Amisulpride—Orthostatic hypotension—Doxorubicin—breast cancer	0.000286	0.000508	CcSEcCtD
Amisulpride—Nervous system disorder—Paclitaxel—breast cancer	0.000286	0.000506	CcSEcCtD
Amisulpride—Urticaria—Mitoxantrone—breast cancer	0.000284	0.000503	CcSEcCtD
Amisulpride—Diarrhoea—Thiotepa—breast cancer	0.000283	0.000502	CcSEcCtD
Amisulpride—Skin disorder—Paclitaxel—breast cancer	0.000283	0.000502	CcSEcCtD
Amisulpride—Abdominal pain—Irinotecan—breast cancer	0.000282	0.000501	CcSEcCtD
Amisulpride—Abdominal pain—Mitoxantrone—breast cancer	0.000282	0.000501	CcSEcCtD
Amisulpride—Muscle spasms—Capecitabine—breast cancer	0.000282	0.000499	CcSEcCtD
Amisulpride—Hyperhidrosis—Paclitaxel—breast cancer	0.000282	0.000499	CcSEcCtD
Amisulpride—Depression—Methotrexate—breast cancer	0.000278	0.000493	CcSEcCtD
Amisulpride—Vomiting—Vinorelbine—breast cancer	0.000275	0.000488	CcSEcCtD
Amisulpride—Tremor—Capecitabine—breast cancer	0.000274	0.000486	CcSEcCtD
Amisulpride—Neutropenia—Epirubicin—breast cancer	0.000274	0.000485	CcSEcCtD
Amisulpride—Dizziness—Thiotepa—breast cancer	0.000274	0.000485	CcSEcCtD
Amisulpride—Hypotension—Paclitaxel—breast cancer	0.000272	0.000483	CcSEcCtD
Amisulpride—Urticaria—Fluorouracil—breast cancer	0.000272	0.000482	CcSEcCtD
Amisulpride—Headache—Vinorelbine—breast cancer	0.000271	0.000481	CcSEcCtD
Amisulpride—Leukopenia—Docetaxel—breast cancer	0.000271	0.00048	CcSEcCtD
Amisulpride—Weight increased—Epirubicin—breast cancer	0.000267	0.000472	CcSEcCtD
Amisulpride—Weight decreased—Epirubicin—breast cancer	0.000265	0.00047	CcSEcCtD
Amisulpride—Hyperglycaemia—Epirubicin—breast cancer	0.000264	0.000468	CcSEcCtD
Amisulpride—Insomnia—Paclitaxel—breast cancer	0.000263	0.000467	CcSEcCtD
Amisulpride—Hypersensitivity—Mitoxantrone—breast cancer	0.000263	0.000467	CcSEcCtD
Amisulpride—Hypersensitivity—Irinotecan—breast cancer	0.000263	0.000467	CcSEcCtD
Amisulpride—Vomiting—Thiotepa—breast cancer	0.000263	0.000466	CcSEcCtD
Amisulpride—Leukopenia—Capecitabine—breast cancer	0.000262	0.000465	CcSEcCtD
Amisulpride—Convulsion—Docetaxel—breast cancer	0.000262	0.000465	CcSEcCtD
Amisulpride—Hypertension—Docetaxel—breast cancer	0.000261	0.000463	CcSEcCtD
Amisulpride—Agranulocytosis—Methotrexate—breast cancer	0.00026	0.000462	CcSEcCtD
Amisulpride—Headache—Thiotepa—breast cancer	0.000259	0.000459	CcSEcCtD
Amisulpride—Somnolence—Paclitaxel—breast cancer	0.000259	0.000459	CcSEcCtD
Amisulpride—Nausea—Vinorelbine—breast cancer	0.000257	0.000456	CcSEcCtD
Amisulpride—Dyspepsia—Paclitaxel—breast cancer	0.000256	0.000455	CcSEcCtD
Amisulpride—Asthenia—Mitoxantrone—breast cancer	0.000256	0.000454	CcSEcCtD
Amisulpride—Asthenia—Irinotecan—breast cancer	0.000256	0.000454	CcSEcCtD
Amisulpride—Neuropathy peripheral—Epirubicin—breast cancer	0.000256	0.000454	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000256	0.000453	CcSEcCtD
Amisulpride—Neutropenia—Doxorubicin—breast cancer	0.000253	0.000449	CcSEcCtD
Amisulpride—Hypertension—Capecitabine—breast cancer	0.000253	0.000448	CcSEcCtD
Amisulpride—Hypersensitivity—Fluorouracil—breast cancer	0.000252	0.000447	CcSEcCtD
Amisulpride—Dry mouth—Docetaxel—breast cancer	0.000252	0.000447	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000252	0.000446	CcSEcCtD
Amisulpride—Fatigue—Paclitaxel—breast cancer	0.000251	0.000445	CcSEcCtD
Amisulpride—Asthenia—Gemcitabine—breast cancer	0.00025	0.000443	CcSEcCtD
Amisulpride—Constipation—Paclitaxel—breast cancer	0.000249	0.000442	CcSEcCtD
Amisulpride—Anxiety—Capecitabine—breast cancer	0.000249	0.000441	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000248	0.000439	CcSEcCtD
Amisulpride—Weight increased—Doxorubicin—breast cancer	0.000247	0.000437	CcSEcCtD
Amisulpride—Pruritus—Gemcitabine—breast cancer	0.000246	0.000436	CcSEcCtD
Amisulpride—Nausea—Thiotepa—breast cancer	0.000246	0.000436	CcSEcCtD
Amisulpride—Weight decreased—Doxorubicin—breast cancer	0.000245	0.000435	CcSEcCtD
Amisulpride—Hyperglycaemia—Doxorubicin—breast cancer	0.000244	0.000433	CcSEcCtD
Amisulpride—Diarrhoea—Mitoxantrone—breast cancer	0.000244	0.000433	CcSEcCtD
Amisulpride—Diarrhoea—Irinotecan—breast cancer	0.000244	0.000433	CcSEcCtD
Amisulpride—Dry mouth—Capecitabine—breast cancer	0.000244	0.000432	CcSEcCtD
Amisulpride—Agranulocytosis—Epirubicin—breast cancer	0.000244	0.000432	CcSEcCtD
Amisulpride—Nervous system disorder—Docetaxel—breast cancer	0.000242	0.000429	CcSEcCtD
Amisulpride—Pruritus—Fluorouracil—breast cancer	0.000242	0.000429	CcSEcCtD
Amisulpride—Skin disorder—Docetaxel—breast cancer	0.00024	0.000425	CcSEcCtD
Amisulpride—Bradycardia—Epirubicin—breast cancer	0.000239	0.000423	CcSEcCtD
Amisulpride—Gastrointestinal pain—Paclitaxel—breast cancer	0.000238	0.000422	CcSEcCtD
Amisulpride—Diarrhoea—Gemcitabine—breast cancer	0.000238	0.000422	CcSEcCtD
Amisulpride—Neuropathy peripheral—Doxorubicin—breast cancer	0.000237	0.00042	CcSEcCtD
Amisulpride—Dizziness—Irinotecan—breast cancer	0.000236	0.000419	CcSEcCtD
Amisulpride—Nervous system disorder—Capecitabine—breast cancer	0.000234	0.000416	CcSEcCtD
Amisulpride—Diarrhoea—Fluorouracil—breast cancer	0.000234	0.000415	CcSEcCtD
Amisulpride—Cardiac disorder—Methotrexate—breast cancer	0.000232	0.000412	CcSEcCtD
Amisulpride—Skin disorder—Capecitabine—breast cancer	0.000232	0.000412	CcSEcCtD
Amisulpride—Urticaria—Paclitaxel—breast cancer	0.000231	0.00041	CcSEcCtD
Amisulpride—Hyperhidrosis—Capecitabine—breast cancer	0.000231	0.00041	CcSEcCtD
Amisulpride—Hypotension—Docetaxel—breast cancer	0.000231	0.000409	CcSEcCtD
Amisulpride—Abdominal pain—Paclitaxel—breast cancer	0.00023	0.000408	CcSEcCtD
Amisulpride—Angiopathy—Methotrexate—breast cancer	0.000227	0.000403	CcSEcCtD
Amisulpride—Vomiting—Irinotecan—breast cancer	0.000227	0.000403	CcSEcCtD
Amisulpride—Vomiting—Mitoxantrone—breast cancer	0.000227	0.000403	CcSEcCtD
Amisulpride—Immune system disorder—Methotrexate—breast cancer	0.000226	0.000401	CcSEcCtD
Amisulpride—Dizziness—Fluorouracil—breast cancer	0.000226	0.000401	CcSEcCtD
Amisulpride—Agranulocytosis—Doxorubicin—breast cancer	0.000225	0.0004	CcSEcCtD
Amisulpride—Headache—Irinotecan—breast cancer	0.000224	0.000397	CcSEcCtD
Amisulpride—Headache—Mitoxantrone—breast cancer	0.000224	0.000397	CcSEcCtD
Amisulpride—Hypotension—Capecitabine—breast cancer	0.000223	0.000396	CcSEcCtD
Amisulpride—Insomnia—Docetaxel—breast cancer	0.000223	0.000396	CcSEcCtD
Amisulpride—Vomiting—Gemcitabine—breast cancer	0.000221	0.000392	CcSEcCtD
Amisulpride—Bradycardia—Doxorubicin—breast cancer	0.000221	0.000391	CcSEcCtD
Amisulpride—Somnolence—Docetaxel—breast cancer	0.00022	0.000389	CcSEcCtD
Amisulpride—Mental disorder—Methotrexate—breast cancer	0.000219	0.000389	CcSEcCtD
Amisulpride—Malnutrition—Methotrexate—breast cancer	0.000218	0.000387	CcSEcCtD
Amisulpride—Headache—Gemcitabine—breast cancer	0.000218	0.000386	CcSEcCtD
Amisulpride—Cardiac disorder—Epirubicin—breast cancer	0.000218	0.000386	CcSEcCtD
Amisulpride—Vomiting—Fluorouracil—breast cancer	0.000218	0.000386	CcSEcCtD
Amisulpride—Dyspepsia—Docetaxel—breast cancer	0.000217	0.000385	CcSEcCtD
Amisulpride—Insomnia—Capecitabine—breast cancer	0.000216	0.000383	CcSEcCtD
Amisulpride—Hypersensitivity—Paclitaxel—breast cancer	0.000215	0.00038	CcSEcCtD
Amisulpride—Headache—Fluorouracil—breast cancer	0.000214	0.00038	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Docetaxel—breast cancer	0.000213	0.000378	CcSEcCtD
Amisulpride—Fatigue—Docetaxel—breast cancer	0.000213	0.000377	CcSEcCtD
Amisulpride—Angiopathy—Epirubicin—breast cancer	0.000213	0.000377	CcSEcCtD
Amisulpride—Nausea—Irinotecan—breast cancer	0.000212	0.000376	CcSEcCtD
Amisulpride—Nausea—Mitoxantrone—breast cancer	0.000212	0.000376	CcSEcCtD
Amisulpride—Immune system disorder—Epirubicin—breast cancer	0.000212	0.000375	CcSEcCtD
Amisulpride—Constipation—Docetaxel—breast cancer	0.000211	0.000374	CcSEcCtD
Amisulpride—Dyspepsia—Capecitabine—breast cancer	0.00021	0.000373	CcSEcCtD
Amisulpride—Asthenia—Paclitaxel—breast cancer	0.000209	0.000371	CcSEcCtD
Amisulpride—Nausea—Gemcitabine—breast cancer	0.000207	0.000366	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Capecitabine—breast cancer	0.000206	0.000366	CcSEcCtD
Amisulpride—Fatigue—Capecitabine—breast cancer	0.000206	0.000365	CcSEcCtD
Amisulpride—Pruritus—Paclitaxel—breast cancer	0.000206	0.000365	CcSEcCtD
Amisulpride—Mental disorder—Epirubicin—breast cancer	0.000205	0.000364	CcSEcCtD
Amisulpride—Constipation—Capecitabine—breast cancer	0.000204	0.000362	CcSEcCtD
Amisulpride—Malnutrition—Epirubicin—breast cancer	0.000204	0.000362	CcSEcCtD
Amisulpride—Nausea—Fluorouracil—breast cancer	0.000203	0.00036	CcSEcCtD
Amisulpride—Gastrointestinal pain—Docetaxel—breast cancer	0.000202	0.000358	CcSEcCtD
Amisulpride—Cardiac disorder—Doxorubicin—breast cancer	0.000201	0.000357	CcSEcCtD
Amisulpride—Tension—Epirubicin—breast cancer	0.0002	0.000355	CcSEcCtD
Amisulpride—Diarrhoea—Paclitaxel—breast cancer	0.000199	0.000353	CcSEcCtD
Amisulpride—Nervousness—Epirubicin—breast cancer	0.000198	0.000351	CcSEcCtD
Amisulpride—Angiopathy—Doxorubicin—breast cancer	0.000197	0.000349	CcSEcCtD
Amisulpride—Muscle spasms—Epirubicin—breast cancer	0.000196	0.000348	CcSEcCtD
Amisulpride—Immune system disorder—Doxorubicin—breast cancer	0.000196	0.000347	CcSEcCtD
Amisulpride—Gastrointestinal pain—Capecitabine—breast cancer	0.000195	0.000347	CcSEcCtD
Amisulpride—Abdominal pain—Docetaxel—breast cancer	0.000195	0.000346	CcSEcCtD
Amisulpride—Leukopenia—Methotrexate—breast cancer	0.000195	0.000346	CcSEcCtD
Amisulpride—Dizziness—Paclitaxel—breast cancer	0.000193	0.000341	CcSEcCtD
Amisulpride—Mental disorder—Doxorubicin—breast cancer	0.00019	0.000337	CcSEcCtD
Amisulpride—Urticaria—Capecitabine—breast cancer	0.00019	0.000337	CcSEcCtD
Amisulpride—Abdominal pain—Capecitabine—breast cancer	0.000189	0.000335	CcSEcCtD
Amisulpride—Convulsion—Methotrexate—breast cancer	0.000189	0.000335	CcSEcCtD
Amisulpride—Malnutrition—Doxorubicin—breast cancer	0.000189	0.000335	CcSEcCtD
Amisulpride—Agitation—Epirubicin—breast cancer	0.000188	0.000332	CcSEcCtD
Amisulpride—Tension—Doxorubicin—breast cancer	0.000185	0.000328	CcSEcCtD
Amisulpride—Vomiting—Paclitaxel—breast cancer	0.000185	0.000328	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000184	0.000327	CcSEcCtD
Amisulpride—Nervousness—Doxorubicin—breast cancer	0.000183	0.000325	CcSEcCtD
Amisulpride—Leukopenia—Epirubicin—breast cancer	0.000183	0.000324	CcSEcCtD
Amisulpride—Headache—Paclitaxel—breast cancer	0.000183	0.000324	CcSEcCtD
Amisulpride—Hypersensitivity—Docetaxel—breast cancer	0.000182	0.000322	CcSEcCtD
Amisulpride—Muscle spasms—Doxorubicin—breast cancer	0.000182	0.000322	CcSEcCtD
Amisulpride—Asthenia—Docetaxel—breast cancer	0.000177	0.000314	CcSEcCtD
Amisulpride—Convulsion—Epirubicin—breast cancer	0.000177	0.000313	CcSEcCtD
Amisulpride—Hypertension—Epirubicin—breast cancer	0.000176	0.000312	CcSEcCtD
Amisulpride—Hypersensitivity—Capecitabine—breast cancer	0.000176	0.000312	CcSEcCtD
Amisulpride—Pruritus—Docetaxel—breast cancer	0.000175	0.00031	CcSEcCtD
Amisulpride—Nervous system disorder—Methotrexate—breast cancer	0.000175	0.000309	CcSEcCtD
Amisulpride—Agitation—Doxorubicin—breast cancer	0.000174	0.000308	CcSEcCtD
Amisulpride—Anxiety—Epirubicin—breast cancer	0.000173	0.000307	CcSEcCtD
Amisulpride—Nausea—Paclitaxel—breast cancer	0.000173	0.000307	CcSEcCtD
Amisulpride—Skin disorder—Methotrexate—breast cancer	0.000173	0.000306	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000173	0.000306	CcSEcCtD
Amisulpride—Hyperhidrosis—Methotrexate—breast cancer	0.000172	0.000305	CcSEcCtD
Amisulpride—Asthenia—Capecitabine—breast cancer	0.000172	0.000304	CcSEcCtD
Amisulpride—Dry mouth—Epirubicin—breast cancer	0.00017	0.000301	CcSEcCtD
Amisulpride—Pruritus—Capecitabine—breast cancer	0.000169	0.0003	CcSEcCtD
Amisulpride—Leukopenia—Doxorubicin—breast cancer	0.000169	0.0003	CcSEcCtD
Amisulpride—Diarrhoea—Docetaxel—breast cancer	0.000169	0.000299	CcSEcCtD
Amisulpride—Hypotension—Methotrexate—breast cancer	0.000166	0.000295	CcSEcCtD
Amisulpride—Convulsion—Doxorubicin—breast cancer	0.000164	0.00029	CcSEcCtD
Amisulpride—Diarrhoea—Capecitabine—breast cancer	0.000164	0.00029	CcSEcCtD
Amisulpride—Nervous system disorder—Epirubicin—breast cancer	0.000163	0.00029	CcSEcCtD
Amisulpride—Dizziness—Docetaxel—breast cancer	0.000163	0.000289	CcSEcCtD
Amisulpride—Hypertension—Doxorubicin—breast cancer	0.000163	0.000289	CcSEcCtD
Amisulpride—Skin disorder—Epirubicin—breast cancer	0.000162	0.000287	CcSEcCtD
Amisulpride—Hyperhidrosis—Epirubicin—breast cancer	0.000161	0.000285	CcSEcCtD
Amisulpride—Insomnia—Methotrexate—breast cancer	0.000161	0.000285	CcSEcCtD
Amisulpride—Anxiety—Doxorubicin—breast cancer	0.00016	0.000284	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.00016	0.000283	CcSEcCtD
Amisulpride—Somnolence—Methotrexate—breast cancer	0.000158	0.00028	CcSEcCtD
Amisulpride—Dizziness—Capecitabine—breast cancer	0.000158	0.00028	CcSEcCtD
Amisulpride—Dry mouth—Doxorubicin—breast cancer	0.000157	0.000279	CcSEcCtD
Amisulpride—Vomiting—Docetaxel—breast cancer	0.000157	0.000278	CcSEcCtD
Amisulpride—Dyspepsia—Methotrexate—breast cancer	0.000157	0.000278	CcSEcCtD
Amisulpride—Hypotension—Epirubicin—breast cancer	0.000156	0.000276	CcSEcCtD
Amisulpride—Headache—Docetaxel—breast cancer	0.000155	0.000274	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Methotrexate—breast cancer	0.000154	0.000272	CcSEcCtD
Amisulpride—Fatigue—Methotrexate—breast cancer	0.000153	0.000272	CcSEcCtD
Amisulpride—Vomiting—Capecitabine—breast cancer	0.000152	0.000269	CcSEcCtD
Amisulpride—Nervous system disorder—Doxorubicin—breast cancer	0.000151	0.000268	CcSEcCtD
Amisulpride—Insomnia—Epirubicin—breast cancer	0.000151	0.000267	CcSEcCtD
Amisulpride—Headache—Capecitabine—breast cancer	0.00015	0.000265	CcSEcCtD
Amisulpride—Skin disorder—Doxorubicin—breast cancer	0.00015	0.000265	CcSEcCtD
Amisulpride—Hyperhidrosis—Doxorubicin—breast cancer	0.000149	0.000264	CcSEcCtD
Amisulpride—Somnolence—Epirubicin—breast cancer	0.000148	0.000262	CcSEcCtD
Amisulpride—Nausea—Docetaxel—breast cancer	0.000147	0.00026	CcSEcCtD
Amisulpride—Dyspepsia—Epirubicin—breast cancer	0.000147	0.00026	CcSEcCtD
Amisulpride—Gastrointestinal pain—Methotrexate—breast cancer	0.000146	0.000258	CcSEcCtD
Amisulpride—Hypotension—Doxorubicin—breast cancer	0.000144	0.000255	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Epirubicin—breast cancer	0.000144	0.000255	CcSEcCtD
Amisulpride—Fatigue—Epirubicin—breast cancer	0.000144	0.000255	CcSEcCtD
Amisulpride—Constipation—Epirubicin—breast cancer	0.000142	0.000252	CcSEcCtD
Amisulpride—Nausea—Capecitabine—breast cancer	0.000142	0.000252	CcSEcCtD
Amisulpride—Urticaria—Methotrexate—breast cancer	0.000141	0.000251	CcSEcCtD
Amisulpride—Abdominal pain—Methotrexate—breast cancer	0.000141	0.000249	CcSEcCtD
Amisulpride—Insomnia—Doxorubicin—breast cancer	0.000139	0.000247	CcSEcCtD
Amisulpride—Somnolence—Doxorubicin—breast cancer	0.000137	0.000243	CcSEcCtD
Amisulpride—Gastrointestinal pain—Epirubicin—breast cancer	0.000136	0.000241	CcSEcCtD
Amisulpride—Dyspepsia—Doxorubicin—breast cancer	0.000136	0.00024	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000133	0.000236	CcSEcCtD
Amisulpride—Fatigue—Doxorubicin—breast cancer	0.000133	0.000236	CcSEcCtD
Amisulpride—Urticaria—Epirubicin—breast cancer	0.000132	0.000235	CcSEcCtD
Amisulpride—Constipation—Doxorubicin—breast cancer	0.000132	0.000234	CcSEcCtD
Amisulpride—Abdominal pain—Epirubicin—breast cancer	0.000132	0.000233	CcSEcCtD
Amisulpride—Hypersensitivity—Methotrexate—breast cancer	0.000131	0.000232	CcSEcCtD
Amisulpride—Asthenia—Methotrexate—breast cancer	0.000128	0.000226	CcSEcCtD
Amisulpride—Gastrointestinal pain—Doxorubicin—breast cancer	0.000126	0.000223	CcSEcCtD
Amisulpride—Pruritus—Methotrexate—breast cancer	0.000126	0.000223	CcSEcCtD
Amisulpride—Hypersensitivity—Epirubicin—breast cancer	0.000123	0.000218	CcSEcCtD
Amisulpride—Urticaria—Doxorubicin—breast cancer	0.000122	0.000217	CcSEcCtD
Amisulpride—Abdominal pain—Doxorubicin—breast cancer	0.000122	0.000216	CcSEcCtD
Amisulpride—Diarrhoea—Methotrexate—breast cancer	0.000122	0.000216	CcSEcCtD
Amisulpride—Asthenia—Epirubicin—breast cancer	0.000119	0.000212	CcSEcCtD
Amisulpride—Pruritus—Epirubicin—breast cancer	0.000118	0.000209	CcSEcCtD
Amisulpride—Dizziness—Methotrexate—breast cancer	0.000118	0.000209	CcSEcCtD
Amisulpride—Diarrhoea—Epirubicin—breast cancer	0.000114	0.000202	CcSEcCtD
Amisulpride—Hypersensitivity—Doxorubicin—breast cancer	0.000114	0.000201	CcSEcCtD
Amisulpride—Vomiting—Methotrexate—breast cancer	0.000113	0.000201	CcSEcCtD
Amisulpride—Headache—Methotrexate—breast cancer	0.000111	0.000198	CcSEcCtD
Amisulpride—Asthenia—Doxorubicin—breast cancer	0.000111	0.000196	CcSEcCtD
Amisulpride—Dizziness—Epirubicin—breast cancer	0.00011	0.000195	CcSEcCtD
Amisulpride—Pruritus—Doxorubicin—breast cancer	0.000109	0.000193	CcSEcCtD
Amisulpride—Vomiting—Epirubicin—breast cancer	0.000106	0.000188	CcSEcCtD
Amisulpride—Nausea—Methotrexate—breast cancer	0.000106	0.000187	CcSEcCtD
Amisulpride—Diarrhoea—Doxorubicin—breast cancer	0.000105	0.000187	CcSEcCtD
Amisulpride—Headache—Epirubicin—breast cancer	0.000104	0.000185	CcSEcCtD
Amisulpride—Dizziness—Doxorubicin—breast cancer	0.000102	0.000181	CcSEcCtD
Amisulpride—Nausea—Epirubicin—breast cancer	9.89e-05	0.000175	CcSEcCtD
Amisulpride—Vomiting—Doxorubicin—breast cancer	9.8e-05	0.000174	CcSEcCtD
Amisulpride—Headache—Doxorubicin—breast cancer	9.65e-05	0.000171	CcSEcCtD
Amisulpride—Nausea—Doxorubicin—breast cancer	9.15e-05	0.000162	CcSEcCtD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CB—breast cancer	1.82e-05	0.000134	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—NOS3—breast cancer	1.82e-05	0.000134	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SPP1—breast cancer	1.79e-05	0.000131	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—MAPK3—breast cancer	1.79e-05	0.000131	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—CXCL8—breast cancer	1.78e-05	0.000131	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ERBB3—breast cancer	1.77e-05	0.00013	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGFR2—breast cancer	1.77e-05	0.00013	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CD—breast cancer	1.76e-05	0.000129	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SPP1—breast cancer	1.76e-05	0.000129	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—BRAF—breast cancer	1.75e-05	0.000129	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—CXCL8—breast cancer	1.75e-05	0.000129	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—PIK3CA—breast cancer	1.75e-05	0.000128	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SERPINE1—breast cancer	1.74e-05	0.000128	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ERBB3—breast cancer	1.74e-05	0.000128	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGFR2—breast cancer	1.74e-05	0.000128	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—PIK3CA—breast cancer	1.74e-05	0.000127	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MDM2—breast cancer	1.73e-05	0.000127	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—KRAS—breast cancer	1.73e-05	0.000127	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RAF1—breast cancer	1.72e-05	0.000126	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—RELA—breast cancer	1.71e-05	0.000126	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IGF1—breast cancer	1.71e-05	0.000125	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT2—breast cancer	1.71e-05	0.000125	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—ERBB2—breast cancer	1.7e-05	0.000125	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL2—breast cancer	1.7e-05	0.000125	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—EGFR—breast cancer	1.7e-05	0.000125	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TERT—breast cancer	1.69e-05	0.000124	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MTOR—breast cancer	1.68e-05	0.000123	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CB—breast cancer	1.68e-05	0.000123	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL2—breast cancer	1.67e-05	0.000123	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TERT—breast cancer	1.67e-05	0.000122	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—NOS3—breast cancer	1.66e-05	0.000122	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FGFR1—breast cancer	1.65e-05	0.000121	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CD—breast cancer	1.64e-05	0.00012	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—PIK3CA—breast cancer	1.62e-05	0.000119	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SERPINE1—breast cancer	1.62e-05	0.000119	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HIF1A—breast cancer	1.62e-05	0.000119	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FGFR1—breast cancer	1.62e-05	0.000119	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CXCL8—breast cancer	1.62e-05	0.000119	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—KRAS—breast cancer	1.61e-05	0.000118	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—HRAS—breast cancer	1.61e-05	0.000118	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HIF1A—breast cancer	1.59e-05	0.000117	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—PIK3CA—breast cancer	1.59e-05	0.000116	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—LEP—breast cancer	1.58e-05	0.000116	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MDM2—breast cancer	1.58e-05	0.000116	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CDKN1B—breast cancer	1.58e-05	0.000116	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RAF1—breast cancer	1.57e-05	0.000116	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CAV1—breast cancer	1.57e-05	0.000115	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—RELA—breast cancer	1.57e-05	0.000115	CbGpPWpGaD
Amisulpride—HTR7—GPCR downstream signaling—AKT1—breast cancer	1.56e-05	0.000115	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—ERBB2—breast cancer	1.56e-05	0.000114	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—LEP—breast cancer	1.56e-05	0.000114	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KDR—breast cancer	1.55e-05	0.000114	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—NOS3—breast cancer	1.55e-05	0.000114	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CASP3—breast cancer	1.55e-05	0.000114	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL2—breast cancer	1.54e-05	0.000113	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CAV1—breast cancer	1.54e-05	0.000113	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CB—breast cancer	1.54e-05	0.000113	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MTOR—breast cancer	1.54e-05	0.000113	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—IL6—breast cancer	1.54e-05	0.000113	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KDR—breast cancer	1.53e-05	0.000112	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ESR1—breast cancer	1.51e-05	0.000111	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CCND1—breast cancer	1.51e-05	0.000111	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—JUN—breast cancer	1.5e-05	0.00011	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—FN1—breast cancer	1.49e-05	0.00011	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CTNNB1—breast cancer	1.49e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ESR1—breast cancer	1.49e-05	0.000109	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CXCL8—breast cancer	1.48e-05	0.000108	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—PIK3CA—breast cancer	1.48e-05	0.000108	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NFKBIA—breast cancer	1.47e-05	0.000108	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MDM2—breast cancer	1.47e-05	0.000108	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—FN1—breast cancer	1.47e-05	0.000108	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—HRAS—breast cancer	1.47e-05	0.000108	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RAF1—breast cancer	1.46e-05	0.000108	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MMP9—breast cancer	1.46e-05	0.000107	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOTCH1—breast cancer	1.46e-05	0.000107	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—RELA—breast cancer	1.46e-05	0.000107	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—CDKN1A—breast cancer	1.46e-05	0.000107	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PTEN—breast cancer	1.45e-05	0.000107	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NFKBIA—breast cancer	1.45e-05	0.000107	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—ERBB2—breast cancer	1.45e-05	0.000106	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CDKN1B—breast cancer	1.44e-05	0.000106	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOTCH1—breast cancer	1.44e-05	0.000106	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MTOR—breast cancer	1.43e-05	0.000105	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CB—breast cancer	1.43e-05	0.000105	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CG—breast cancer	1.43e-05	0.000105	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KIT—breast cancer	1.43e-05	0.000105	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—APC—breast cancer	1.43e-05	0.000105	CbGpPWpGaD
Amisulpride—HTR2B—GPCR downstream signaling—AKT1—breast cancer	1.43e-05	0.000105	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MAPK8—breast cancer	1.42e-05	0.000104	CbGpPWpGaD
Amisulpride—HTR7—Signaling by GPCR—AKT1—breast cancer	1.42e-05	0.000104	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CASP3—breast cancer	1.41e-05	0.000104	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGF—breast cancer	1.41e-05	0.000104	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL2—breast cancer	1.41e-05	0.000104	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CG—breast cancer	1.4e-05	0.000103	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—APC—breast cancer	1.4e-05	0.000103	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KIT—breast cancer	1.4e-05	0.000103	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—IL6—breast cancer	1.4e-05	0.000103	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGF—breast cancer	1.39e-05	0.000102	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CCND1—breast cancer	1.38e-05	0.000101	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CXCL8—breast cancer	1.37e-05	0.000101	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—JUN—breast cancer	1.37e-05	0.000101	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—MAPK3—breast cancer	1.37e-05	0.0001	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—HRAS—breast cancer	1.37e-05	0.0001	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CTNNB1—breast cancer	1.36e-05	0.0001	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—SRC—breast cancer	1.35e-05	9.9e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—MAPK3—breast cancer	1.35e-05	9.88e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—BRAF—breast cancer	1.34e-05	9.86e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CDKN1B—breast cancer	1.34e-05	9.85e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MMP9—breast cancer	1.34e-05	9.81e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—CDKN1A—breast cancer	1.33e-05	9.77e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PTEN—breast cancer	1.33e-05	9.75e-05	CbGpPWpGaD
Amisulpride—DRD3—GPCR downstream signaling—AKT1—breast cancer	1.33e-05	9.75e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—BRAF—breast cancer	1.32e-05	9.7e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CASP3—breast cancer	1.32e-05	9.66e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL2—breast cancer	1.31e-05	9.64e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—VEGFA—breast cancer	1.31e-05	9.64e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IGF1—breast cancer	1.31e-05	9.6e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—IL6—breast cancer	1.31e-05	9.59e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT2—breast cancer	1.31e-05	9.59e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—EGFR—breast cancer	1.3e-05	9.55e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—STAT3—breast cancer	1.3e-05	9.54e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAPK8—breast cancer	1.3e-05	9.54e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling by GPCR—AKT1—breast cancer	1.3e-05	9.51e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IGF1—breast cancer	1.29e-05	9.45e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT2—breast cancer	1.29e-05	9.44e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CCND1—breast cancer	1.28e-05	9.4e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—EGFR—breast cancer	1.28e-05	9.4e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—JUN—breast cancer	1.28e-05	9.38e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CTNNB1—breast cancer	1.27e-05	9.31e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CD—breast cancer	1.26e-05	9.22e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	1.24e-05	9.13e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MMP9—breast cancer	1.24e-05	9.13e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MAPK3—breast cancer	1.24e-05	9.12e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SERPINE1—breast cancer	1.24e-05	9.12e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—CDKN1A—breast cancer	1.24e-05	9.09e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PTEN—breast cancer	1.24e-05	9.07e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CD—breast cancer	1.24e-05	9.07e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—SRC—breast cancer	1.23e-05	9.04e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—KRAS—breast cancer	1.23e-05	9.02e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—PIK3CA—breast cancer	1.22e-05	8.98e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SERPINE1—breast cancer	1.22e-05	8.97e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—KRAS—breast cancer	1.21e-05	8.88e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAPK8—breast cancer	1.21e-05	8.88e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—MYC—breast cancer	1.21e-05	8.87e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling by GPCR—AKT1—breast cancer	1.21e-05	8.85e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TGFB1—breast cancer	1.2e-05	8.85e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—VEGFA—breast cancer	1.2e-05	8.81e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—STAT3—breast cancer	1.19e-05	8.72e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—NOS3—breast cancer	1.19e-05	8.7e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—EGFR—breast cancer	1.18e-05	8.67e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—NOS3—breast cancer	1.17e-05	8.56e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—SRC—breast cancer	1.15e-05	8.41e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MAPK3—breast cancer	1.13e-05	8.33e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—PIK3CA—breast cancer	1.13e-05	8.29e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MDM2—breast cancer	1.12e-05	8.26e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RAF1—breast cancer	1.12e-05	8.23e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—VEGFA—breast cancer	1.12e-05	8.2e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—KRAS—breast cancer	1.12e-05	8.19e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—RELA—breast cancer	1.12e-05	8.19e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—PIK3CA—breast cancer	1.11e-05	8.16e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—ERBB2—breast cancer	1.11e-05	8.14e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MDM2—breast cancer	1.11e-05	8.13e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—STAT3—breast cancer	1.11e-05	8.11e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—MYC—breast cancer	1.1e-05	8.1e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RAF1—breast cancer	1.1e-05	8.1e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TGFB1—breast cancer	1.1e-05	8.08e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—RELA—breast cancer	1.1e-05	8.06e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CB—breast cancer	1.09e-05	8.03e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MTOR—breast cancer	1.09e-05	8.03e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—ERBB2—breast cancer	1.09e-05	8.01e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—EGFR—breast cancer	1.08e-05	7.93e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MTOR—breast cancer	1.08e-05	7.91e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CB—breast cancer	1.08e-05	7.91e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MAPK3—breast cancer	1.06e-05	7.75e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CXCL8—breast cancer	1.05e-05	7.72e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—HRAS—breast cancer	1.04e-05	7.67e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CXCL8—breast cancer	1.03e-05	7.6e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—HRAS—breast cancer	1.03e-05	7.55e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CDKN1B—breast cancer	1.03e-05	7.54e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—MYC—breast cancer	1.03e-05	7.54e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—PIK3CA—breast cancer	1.03e-05	7.53e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TGFB1—breast cancer	1.02e-05	7.52e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—KRAS—breast cancer	1.02e-05	7.49e-05	CbGpPWpGaD
Amisulpride—DRD2—GPCR downstream signaling—AKT1—breast cancer	1.02e-05	7.46e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CDKN1B—breast cancer	1.01e-05	7.42e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CASP3—breast cancer	1.01e-05	7.39e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL2—breast cancer	1e-05	7.38e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—EGFR—breast cancer	1e-05	7.38e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—IL6—breast cancer	1e-05	7.34e-05	CbGpPWpGaD
Amisulpride—HTR2A—GPCR downstream signaling—AKT1—breast cancer	9.99e-06	7.34e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—TP53—breast cancer	9.92e-06	7.28e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CASP3—breast cancer	9.9e-06	7.27e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL2—breast cancer	9.89e-06	7.26e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—IL6—breast cancer	9.84e-06	7.22e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CCND1—breast cancer	9.8e-06	7.19e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—JUN—breast cancer	9.77e-06	7.18e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CTNNB1—breast cancer	9.7e-06	7.12e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CCND1—breast cancer	9.64e-06	7.08e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—JUN—breast cancer	9.62e-06	7.06e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CTNNB1—breast cancer	9.54e-06	7.01e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MMP9—breast cancer	9.51e-06	6.98e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—KRAS—breast cancer	9.49e-06	6.97e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—HRAS—breast cancer	9.48e-06	6.96e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—CDKN1A—breast cancer	9.48e-06	6.96e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PTEN—breast cancer	9.45e-06	6.94e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—PIK3CA—breast cancer	9.37e-06	6.88e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MMP9—breast cancer	9.36e-06	6.87e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—CDKN1A—breast cancer	9.32e-06	6.85e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PTEN—breast cancer	9.3e-06	6.83e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAPK8—breast cancer	9.25e-06	6.79e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling by GPCR—AKT1—breast cancer	9.22e-06	6.77e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAPK8—breast cancer	9.1e-06	6.68e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—IL6—breast cancer	9.08e-06	6.67e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling by GPCR—AKT1—breast cancer	9.08e-06	6.66e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—TP53—breast cancer	9.06e-06	6.65e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—SRC—breast cancer	8.77e-06	6.44e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—PIK3CA—breast cancer	8.72e-06	6.4e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—HRAS—breast cancer	8.67e-06	6.36e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—SRC—breast cancer	8.63e-06	6.34e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—VEGFA—breast cancer	8.54e-06	6.27e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—STAT3—breast cancer	8.46e-06	6.21e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—TP53—breast cancer	8.43e-06	6.19e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—VEGFA—breast cancer	8.4e-06	6.17e-05	CbGpPWpGaD
Amisulpride—HTR7—Signaling Pathways—AKT1—breast cancer	8.37e-06	6.15e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—STAT3—breast cancer	8.32e-06	6.11e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—IL6—breast cancer	8.3e-06	6.09e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MAPK3—breast cancer	8.08e-06	5.93e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—HRAS—breast cancer	8.06e-06	5.92e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MAPK3—breast cancer	7.95e-06	5.84e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—MYC—breast cancer	7.86e-06	5.77e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TGFB1—breast cancer	7.84e-06	5.76e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—MYC—breast cancer	7.73e-06	5.68e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—IL6—breast cancer	7.72e-06	5.67e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TGFB1—breast cancer	7.71e-06	5.66e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—EGFR—breast cancer	7.68e-06	5.64e-05	CbGpPWpGaD
Amisulpride—HTR2B—Signaling Pathways—AKT1—breast cancer	7.65e-06	5.62e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—EGFR—breast cancer	7.56e-06	5.55e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—KRAS—breast cancer	7.26e-06	5.33e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—KRAS—breast cancer	7.14e-06	5.25e-05	CbGpPWpGaD
Amisulpride—DRD3—Signaling Pathways—AKT1—breast cancer	7.12e-06	5.23e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—PIK3CA—breast cancer	6.67e-06	4.9e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—PIK3CA—breast cancer	6.56e-06	4.82e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—TP53—breast cancer	6.45e-06	4.74e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—TP53—breast cancer	6.35e-06	4.66e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—HRAS—breast cancer	6.17e-06	4.53e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—HRAS—breast cancer	6.07e-06	4.46e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—IL6—breast cancer	5.91e-06	4.34e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—IL6—breast cancer	5.81e-06	4.27e-05	CbGpPWpGaD
Amisulpride—DRD2—Signaling Pathways—AKT1—breast cancer	5.45e-06	4e-05	CbGpPWpGaD
Amisulpride—HTR2A—Signaling Pathways—AKT1—breast cancer	5.36e-06	3.94e-05	CbGpPWpGaD
